Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
When the AI stock chorus gets loud, picking one winner feels daunting. This article explains why a low-cost AI ETF ca...
Two stalwarts of the insurance world compete for a spot in a 2026 portfolio. This article breaks down Lincoln Nationa...
SpaceX aims to push humanity beyond Earth, and its IPO could redefine tech investing. This guide breaks down how mult...
When the market wakes up to a notable move in Smucker shares, it often signals more than a one-off beat. This article...
After a prolonged rally, the AI-heavy trade just worst stretch put gains on pause. This article outlines three clear ...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
New on-chain data points to activity investor capitulation extremes for XRP, with profitability shrinking and transac...
SMH investors are entering a pivotal July earnings season, with hyperscaler capex guidance set to determine the ETF's...
A Washington state man was sentenced to five years in federal prison for helping launder roughly $100 million in cryp...
Fidelity's 2026 study finds workers switch jobs about six times, leaving many with several old retirement accounts. F...
Tesla's China Sales Just Jumped 22% in May, ending a slump. This article breaks down what's behind the rebound, wheth...